Benign Prostatic Hypertrophy Implants Market Snapshot

Published July 2023 | 9 Pages | 5 Exhibits | Forecasts Through 2027

Order individually or subscribe to Medtech Pro and get a complete intel platform.

Overview

This market snapshot from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. 

This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:

  • Unit volumes from 2022 to 2027
  • Market forecasts from 2022 to 2027
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Butterly Medical

Endotherapeutics

Olympus

ProArc

ProVerum

Teleflex

Urotronic

ZenFlow

Companies We Work With